Application of licochalcone A in preparation of medicine for treating metabolic disorder
The invention provides an application of a licochalcone compound LCA (licochalcone A) in preparation of a medicine for treating metabolic disorders, which is characterized in that after a T2DM (Type 2 diabetes mellitus) model mouse is subjected to intraperitoneal injection of the licochalcone A, the licochalcone A is found to be capable of stably reducing the blood sugar and glycated serum protein (GSP) level of the T2DM model mouse, improving the insulin sensitivity, and reducing the toxic and side effects of the T2DM model mouse, so that the application of the licochalcone A in preparation of the medicine for treating the metabolic disorders is realized. No obvious side effect exists. The invention further provides related research and application of the licochalcone A in the aspects of glycometabolism and energy metabolism..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 26. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LIU YING [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-26, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 |
|---|
| Patentnummer: |
CN116803386 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018779948 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018779948 | ||
| 003 | DE-627 | ||
| 005 | 20231222111114.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231222s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018779948 | ||
| 035 | |a (EPA)CN116803386 | ||
| 035 | |a (EPA)88080539 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LIU YING |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of licochalcone A in preparation of medicine for treating metabolic disorder |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-26, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 | ||
| 520 | |a The invention provides an application of a licochalcone compound LCA (licochalcone A) in preparation of a medicine for treating metabolic disorders, which is characterized in that after a T2DM (Type 2 diabetes mellitus) model mouse is subjected to intraperitoneal injection of the licochalcone A, the licochalcone A is found to be capable of stably reducing the blood sugar and glycated serum protein (GSP) level of the T2DM model mouse, improving the insulin sensitivity, and reducing the toxic and side effects of the T2DM model mouse, so that the application of the licochalcone A in preparation of the medicine for treating the metabolic disorders is realized. No obvious side effect exists. The invention further provides related research and application of the licochalcone A in the aspects of glycometabolism and energy metabolism. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG DOUDOU |4 aut | |
| 700 | 0 | |a YANG LIN |4 aut | |
| 700 | 0 | |a DING WENWEN |4 aut | |
| 700 | 0 | |a CHEN ZIYI |4 aut | |
| 700 | 0 | |a YANG XIAOXUE |4 aut | |
| 700 | 0 | |a CHENG YUBIAO |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 26. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:26 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88080539/publication/CN116803386A1?q=CN116803386 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 26 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 26 |c 09 | ||